Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Rising Oral Doses of BI 1021958 in Otherwise Healthy Controlled Asthmatic Subjects
Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Boehringer Ingelheim
Age
18–55
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
1\. Healthy male and female subjects ofn non child-bearing potential
You may not be if
1\. Any relevant deviation from healthy conditions except mild controlled asthma
Clareo Health | Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Rising Oral Doses of BI 1021958 in Otherwise Healthy Controlled Asthmatic Subjects
